2396 The potential metastatic suppressor role of WISP-2 in gastric cancer cells and its correlation with epithelial to mesenchymal transition (EMT)

2015 ◽  
Vol 51 ◽  
pp. S469
Author(s):  
J. Ji ◽  
W.G. Jiang
2017 ◽  
Vol 82 (6) ◽  
pp. 707-714 ◽  
Author(s):  
Jing Feng ◽  
Xiaojuan Wang ◽  
Weihua Zhu ◽  
Si Chen ◽  
Changwei Feng

2021 ◽  
Vol 16 (1) ◽  
pp. 27-33
Author(s):  
Yi Zhou ◽  
Liguo Wang ◽  
Hui Lin ◽  
Yunxia Wang ◽  
Kezhu Hou

This study was designed to evaluate the anti-cancer effects of bufalin against the human gastric cancer cells and unveil the underlying mechanism. The results showed that bufalin inhibited the proliferation and colony formation of the MGC-803 gastric cancer cells and exhibited an IC50 of 10 μM. These antiproliferative effects were found to be due to the induction of G2/M cell cycle arrest. The G2/M cell cycle arrest was also concomitant with inhibition of cdc2, cdc25 and cyclin B1. Furthermore, bufalin suppressed the epithelial-to-mesenchymal transition, migration, and invasion of the MGC-803 gastric cancer cells. The Western blot analysis revealed that bufalin exerted its effects via deactivation of EK/ERK signaling pathway. Taken together, these results suggest the potential of bufalin as the lead molecule for the development of chemotherapy for gastric cancer.  


Sign in / Sign up

Export Citation Format

Share Document